Conduit Pharmaceuticals sets the bar with AI in drug development and autoimmune therapies
Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a clinical-stage life sciences company, is making waves in the pharmaceutical industry by harnessing artificial intelligence (AI) and fostering high-impact ... Read More
Rakovina Therapeutics’ private placement fuels DNA-damage response therapies
Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company pioneering innovative cancer therapies through advancements in DNA-damage response technologies, has successfully closed an oversubscribed private placement ... Read More